Daesung Hi-Tech to Invest 30 Billion Won in Establishing Dedicated Medical Device Production Facility at Daegu Technopolis

On April 7, the city of Daegu signed an investment agreement at the Sangeok Office Building of Daegu City Hall with Daesung Hi-Tech Co., Ltd. (Co-CEOs: Choi Woo-gak and Choi Ho-hyung), a specialist in ultra-precision parts manufacturing, to establish an "AI Autonomous Manufacturing System-Based Medical Factory."

Under this agreement, Daesung Hi-Tech will invest 30 billion won in its headquarters site within Daegu Technopolis to establish a dedicated production base for medical devices, named the "AI Medical Factory."

Sangyeok Office, Daegu City Hall

The company plans to gradually expand its mass production line by 2029, aiming for full operation by September this year. In particular, it will focus on technological advancement by investing 12 billion won of government support funds, secured through the Ministry of Trade, Industry and Energy's "AI Autonomous Manufacturing Leading Project," into research and development (R&D).

Founded in 1995, Daesung Hi-Tech is a global small giant that supplies key components for advanced industries such as semiconductors, IT, and electric vehicles, based on its ultra-precision processing technology that does not tolerate even a 1-micrometer (μm) margin of error.

In 2014, the company acquired Nomura DS (formerly Nomura VTC), a Japanese automatic lathe brand with a 70-year tradition, thus securing world-class Swiss-type automatic lathe manufacturing technology. Currently, it exports products to 27 countries worldwide.

Recently, Daesung Hi-Tech has expanded its business scope to the defense and robotics sectors, achieving visible results, and has also established a local production base in Romania to address the European defense market.

The main product of the newly established "AI Medical Factory" will be the Introducer Catheter, an essential medical device for minimally invasive interventional procedures. Since the entire domestic demand is currently met by imports, localization is urgently needed. Multiple domestic medical companies have already expressed their intention to purchase, so the company expects a swift entry into the market.

Daesung Hi-Tech plans to move away from traditional manual processes by introducing the "AI Autonomous Manufacturing System," which integrates AI-based visual inspection, collaborative robots, and process intelligence technologies. Through this transformation, the company aims to demonstrate unrivaled global competitiveness in the high value-added medical device market.

Choi Ho-hyung, CEO of Daesung Hi-Tech, stated, "Building on our accumulated technological capabilities in precision parts, we have expanded our business areas into defense, robotics, and AI data centers, and now we are making a full-fledged entry into the medical device sector. Through the AI autonomous manufacturing system, we will secure global competitiveness in the high value-added medical device market and contribute to revitalizing the local economy."

Kim Jeonggi, Acting Mayor and Deputy Mayor for Administrative Affairs of Daegu, said, "Daesung Hi-Tech, as a representative local materials, parts, and equipment company, is taking Daegu's manufacturing competitiveness to the next level with its AI autonomous manufacturing investment. We will provide full support to ensure the successful establishment of the AI Medical Factory and its preemptive entry into the global market."

This content was produced with the assistance of AI translation services.